Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND applications for phase I study of CAD-9303 in schizophrenia

March 11, 2020

Brilacidin to be tested against COVID-19

March 11, 2020

Mesoblast to evaluate remestemcel-L for treatment of COVID-19 lung disease

March 11, 2020

NCI selects Curadigm's Nanoprimer technology for characterization

March 11, 2020

AbbVie begins first-in-human study of ABBV-184 in previously treated AML and NSCLC

March 11, 2020

Decoy exosomes fight bacterial toxin

March 11, 2020

'Gut bug' has intratumoral effects

March 11, 2020

IPH-5201 begins first-in-human study in advanced solid tumors

March 10, 2020

FDA approves Ofev for chronic fibrosing interstitial lung diseases with a progressive phenotype

March 10, 2020

Ascletis offers update on Chinese trial of Ganovo and ritonavir for novel coronavirus pneumonia

March 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...